Liver Cirrhosis and Portal Hypertension

References

1. • Garcia-Tsao G.
   • Abraldes J.G.
   • Berzigotti A.
   • et al.
   Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.
   Hepatology. 2017; 65 ([Erratum appears in Hepatology 2017;66(1):304]): 310-335
   View in Article

   • Google Scholar
2. • D'Amico G.
   • Pagliaro L.
   • Bosch J.
   The treatment of portal hypertension: a meta-analytic review.
   Hepatology. 1995; 22: 332-354
   View in Article

   • Google Scholar
3. • Merli M.
   • Nicolini G.
   • Angeloni S.
   • et al.
   Incidence and natural history of small esophageal varices in cirrhotic patients.
   J Hepatol. 2003; 38: 266-272
   View in Article

   • Google Scholar
4. • Amitrano L.
   • Guardascione M.A.
   • Manguso F.
   • et al.
   The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors.
   Am J Gastroenterol. 2012; 107: 1872-1878
   View in Article

   • Google Scholar
5. • Fortune B.E.
   • Garcia-Tsao G.
   • Ciarleglio M.
   • et al.
   • Vapreotide Study Group
   Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study.
   J Clin Gastroenterol. 2017; 51: 446-453
   View in Article

   • Google Scholar
6. • Sarin S.K.
   • Lahoti D.
   • Saxena S.P.
   • et al.
   Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.
   Hepatology. 1992; 16: 1343-1349
   View in Article

   • Google Scholar
7. • Gracia-Sancho J.
   • Caparrós E.
   • Fernández-Iglesias A.
   • et al.
   Role of liver sinusoidal endothelial cells in liver diseases.
   Nat Rev Gastroenterol Hepatol. 2021; 18: 411-431
   View in Article

   • Google Scholar
8. • Tsuchida T.
   • Friedman S.L.
   Mechanisms of hepatic stellate cell activation.
   Nat Rev Gastroenterol Hepatol. 2017; 14: 397-411
   View in Article

   • Google Scholar
9. • Wanless I.R.
   • Wong F.
   • Blendis L.M.
   • et al.
   Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.
   Hepatology. 1995; 21 (PMID: 7737629): 1238-1247
   View in Article

   • Google Scholar
10. • Tripodi A.
    Hemostasis abnormalities in cirrhosis.
    Curr Opin Hematol. 2015; 22: 406-412
    View in Article

    • Google Scholar
11. • Baffy G.
    Potential mechanisms linking gut microbiota and portal hypertension.
    Liver Int. 2019; 39: 598-609
    View in Article

    • Google Scholar
12. • Trebicka J.
    • Macnaughtan J.
    • Schnabl B.
    • et al.
    The microbiota in cirrhosis and its role in hepatic decompensation.
    J Hepatol. 2021; 75: S67-S81
    View in Article

    • Google Scholar
13. • Arab J.P.
    • Martin-Mateos R.M.
    • Shah V.H.
    Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Hepatol Int. 2018; 12: 24-33
    View in Article

    • Google Scholar
14. • Bosch J.
    • Abraldes J.G.
    • Berzigotti A.
    • et al.
    The clinical use of HVPG measurements in chronic liver disease.
    Nat Rev Gastroenterol Hepatol. 2009; 6: 573-582
    View in Article

    • Google Scholar
15. • Berzigotti A.
    • Rossi V.
    • Tiani C.
    • et al.
    Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension.
    J Gastroenterol. 2011; 46: 687-695
    View in Article

    • Google Scholar
16. • Ripoll C.
    • Groszmann R.
    • Garcia-Tsao G.
    • et al.
    • Portal Hypertension Collaborative Group
    Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Gastroenterology. 2007; 133: 481-488
    View in Article

    • Google Scholar
17. • de Franchis R.
    Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.
    J Hepatol. 2000; 33: 846-852
    View in Article

    • Google Scholar
18. • Hutchinson S.J.
    • Bird S.M.
    • Goldberg D.J.
    Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis.
    Clin Gastroenterol Hepatol. 2005; 3: 1150-1159
    View in Article

    • Google Scholar
19. • Ripoll C.
    • Groszmann R.J.
    • Garcia-Tsao G.
    • et al.
    • Portal Hypertension Collaborative Group
    Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
    J Hepatol. 2009; 50: 923-928
    View in Article

    • Google Scholar
20. • You M.W.
    • Kim K.W.
    • Pyo J.
    • et al.
    A Meta-analysis for the Diagnostic Performance of Transient Elastography for Clinically Significant Portal Hypertension.
    Ultrasound Med Biol. 2017; 43: 59-68
    View in Article

    • Google Scholar
21. • Reiberger T.
    The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis.
    Hepatol Commun. 2022; 6: 950-964
    View in Article

    • Google Scholar
22. • de Franchis R.
    • VI Faculty B.
    Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.
    J Hepatol. 2015; 63: 743-752
    View in Article

    • Google Scholar
23. • Vuille-Lessard É
    • Rodrigues S.G.
    • Berzigotti A.
    Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease.
    Clin Liver Dis. 2021; 25: 253-289
    View in Article

    • Google Scholar
24. • Jothimani D.
    • Danielraj S.
    • Nallathambi B.
    • et al.
    Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic.
    Clin Radiol. 2021; 76: 550.e1-550.e7
    View in Article

    • Google Scholar
25. • Tripathi D.
    • Stanley A.J.
    • Hayes P.C.
    • et al.
    Clinical Services and Standards Committee of the British Society of Gastroenterology. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.
    Gut. 2015; 64: 1680-1704
    View in Article

    • Google Scholar
26. • de Franchis R.
    • Bosch J.
    • Garcia-Tsao G.
    • et al.
    • Baveno VII Faculty
    Baveno VII - Renewing consensus in portal hypertension.
    J Hepatol. 2022; 76 (Erratum in: J Hepatol. 2022 Apr 14): 959-974
    View in Article

    • Google Scholar
27. • Wang Q.
    • Zhao H.
    • Deng Y.
    • et al.
    Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis.
    J Hepatol. 2022; 77: 1564-1572
    View in Article

    • Google Scholar
28. • Lebrec D.
    • Poynard T.
    • Hillon P.
    • et al.
    Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.
    N Engl J Med. 1981; 305: 1371-1374
    View in Article

    • Google Scholar
29. • Pascal J.P.
    • Cales P.
    Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.
    N Engl J Med. 1987; 317 (Erratum in: N Engl J Med 1988 Apr 14;318(15):994): 856-861
    View in Article

    • Google Scholar
30. • Garcia-Tsao G.
    • Bosch J.
    Management of varices and variceal hemorrhage in cirrhosis.
    N Engl J Med. 2010; 362 (Erratum in: N Engl J Med. 2011 Feb 3;364(5):490. Dosage error in article text): 823-832
    View in Article

    • Google Scholar
31. • Conn H.O.
    • Grace N.D.
    • Bosch J.
    • et al.
    Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.
    Hepatology. 1991; 13 (PMID: 2029994): 902-912
    View in Article

    • Google Scholar
32. • Teran J.C.
    • Imperiale T.F.
    • Mullen K.D.
    • et al.
    Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis.
    Gastroenterology. 1997; 112: 473-482
    View in Article

    • Google Scholar
33. • Pérez-Ayuso R.M.
    • Valderrama S.
    • Espinoza M.
    • et al.
    Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices.
    Ann Hepatol. 2010; 9 (PMID: 20308718): 15-22
    View in Article

    • Google Scholar
34. • Rockey D.C.
    Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.
    Curr Gastroenterol Rep. 2006; 8: 7-13
    View in Article

    • Google Scholar
35. • Burroughs A.K.
    • Tsochatzis E.A.
    • Triantos C.
    Primary prevention of variceal haemorrhage: a pharmacological approach.
    J Hepatol. 2010; 52: 946-948
    View in Article

    • Google Scholar
36. • Villanueva C.
    • Torres F.
    • Sarin S.K.
    • et al.
    Carvedilol-IPD-MA-group and the Baveno Cooperation: an EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.
    J Hepatol. 2022; 77: 1014-1025
    View in Article

    • Google Scholar
37. • Tripathi D.
    • Ferguson J.W.
    • Kochar N.
    • et al.
    Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.
    Hepatology. 2009; 50: 825-833
    View in Article

    • Google Scholar
38. • Shah H.A.
    • Azam Z.
    • Rauf J.
    • et al.
    Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
    J Hepatol. 2014; 60: 757-764
    View in Article

    • Google Scholar
39. • Zafra C.
    • Abraldes J.G.
    • Turnes J.
    • et al.
    Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.
    Gastroenterology. 2004; 126: 749-755
    View in Article

    • Google Scholar
40. • Abraldes J.G.
    • Albillos A.
    • Bañares R.
    • et al.
    Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Gastroenterology. 2009; 136: 1651-1658
    View in Article

    • Google Scholar
41. • Vijayaraghavan R.
    • Jindal A.
    • Arora V.
    • et al.
    Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Am J Gastroenterol. 2020; 115: 729-737
    View in Article

    • Google Scholar
42. • Abraldes J.G.
    • Villanueva C.
    • Aracil C.
    • et al.
    • BLEPS Study Group
    Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
    Gastroenterology. 2016; 150 (e3): 1160-1170
    View in Article

    • Google Scholar
43. • Thalheimer U.
    • Triantos C.K.
    • Samonakis D.N.
    • et al.
    Infection, coagulation, and variceal bleeding in cirrhosis.
    Gut. 2005; 54: 556-563
    View in Article

    • Google Scholar
44. • Villanueva C.
    • Colomo A.
    • Bosch A.
    • et al.
    Transfusion strategies for acute upper gastrointestinal bleeding.
    N Engl J Med. 2013; 368 (Erratum in: N Engl J Med. 2013;368(24):2341): 11-21
    View in Article

    • Google Scholar
45. • Zhou X.
    • Tripathi D.
    • Song T.
    • et al.
    Terlipressin for the treatment of acute variceal bleeding: A systematic review and meta-analysis of randomized controlled trials.
    Medicine (Baltimore). 2018; 97: e13437
    View in Article

    • Google Scholar
46. • Cavallin M.
    • Piano S.
    • Romano A.
    • et al.
    Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.
    Hepatology. 2016; 63: 983-992
    View in Article

    • Google Scholar
47. • Abid S.
    • Jafri W.
    • Hamid S.
    • et al.
    Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
    Am J Gastroenterol. 2009; 104: 617-623
    View in Article

    • Google Scholar
48. • Seo Y.S.
    • Park S.Y.
    • Kim M.Y.
    • et al.
    Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.
    Hepatology. 2014; 60: 954-963
    View in Article

    • Google Scholar
49. • Yan X.
    • Leng Z.
    • Xu Q.
    • et al.
    The influences of timing of urgent endoscopy in patients with acute variceal bleeding: a cohort study.
    BMC Gastroenterol. 2022; 22: 506
    View in Article

    • Google Scholar
50. • Thabut D.
    • Bernard-Chabert B.
    Management of acute bleeding from portal hypertension.
    Best Pract Res Clin Gastroenterol. 2007; 21: 19-29
    View in Article

    • Google Scholar
51. • Bañares R.
    • Albillos A.
    • Rincón D.
    • et al.
    Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis.
    Hepatology. 2002; 35: 609-615
    View in Article

    • Google Scholar
52. • Garcia-Tsao G.
    • Sanyal A.J.
    • Grace N.D.
    • et al.
    Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.
    Am J Gastroenterol. 2007; 102 (Erratum in: Am J Gastroenterol. 2007 Dec;102(12):2868): 2086-2102
    View in Article

    • Google Scholar
53. • Kumar S.
    • Asrani S.K.
    • Kamath P.S.
    Epidemiology, diagnosis and early patient management of esophagogastric hemorrhage.
    Gastroenterol Clin North Am. 2014; 43: 765-782
    View in Article

    • Google Scholar
54. • García-Pagán J.C.
    • Caca K.
    • Bureau C.
    • et al.
    Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding.
    N Engl J Med. 2010; 362: 2370-2379
    View in Article

    • Google Scholar
55. • Hernández-Gea V.
    • Procopet B.
    • Giráldez Á.
    • et al.
    International Variceal Bleeding Observational Study Group and Baveno Cooperation. Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.
    Hepatology. 2019; 69: 282-293
    View in Article

    • Google Scholar
56. • Jakab S.S.
    • Garcia-Tsao G.
    Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis.
    Clin Liver Dis. 2020; 24: 335-350
    View in Article

    • Google Scholar
57. • Yu Q.
    • Huang Y.
    • Li X.
    • et al.
    An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension.
    Cell Rep Med. 2022; 3: 100563
    View in Article

    • Google Scholar
58. • Agarwal S.
    • Sharma S.
    • Kumar M.
    • et al.
    Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept.
    J Gastroenterol Hepatol. 2021; 36: 2935-2942
    View in Article

    • Google Scholar
59. • Wang Y.
    • Hong Y.
    • Wang Y.
    • et al.
    Automated Multimodal Machine Learning for Esophageal Variceal Bleeding Prediction Based on Endoscopy and Structured Data.
    J Digit Imaging. 2022; https://doi.org/10.1007/s10278-022-00724-6
    View in Article

    • Google Scholar